BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16325212)

  • 1. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
    Zhu JJ; Li FB; Zhu XF; Liao WM
    Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor p33ING1b enhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells.
    Zhu JJ; Li FB; Zhou JM; Liu ZC; Zhu XF; Liao WM
    Cancer Biol Ther; 2005 Jan; 4(1):39-47. PubMed ID: 15662138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis.
    Allan LA; Fried M
    Oncogene; 1999 Sep; 18(39):5403-12. PubMed ID: 10498894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
    Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
    Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
    Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
    Xie XK; Yang DS; Ye ZM; Tao HM
    Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.
    Maurich T; Iorio M; Chimenti D; Turchi G
    Chem Biol Interact; 2006 Feb; 159(2):104-16. PubMed ID: 16271357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells.
    Zhuang SM; Shvarts A; van Ormondt H; Jochemsen AG; van der Eb AJ; Noteborn MH
    Cancer Res; 1995 Feb; 55(3):486-9. PubMed ID: 7834613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
    Mizuarai S; Yamanaka K; Kotani H
    Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
    Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroptychantol A, a macrocyclic bisbibenzyl derivative, induces autophagy and following apoptosis associated with p53 pathway in human osteosarcoma U2OS cells.
    Li X; Wu WK; Sun B; Cui M; Liu S; Gao J; Lou H
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):146-54. PubMed ID: 21185854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
    Cheung KJ; Mitchell D; Lin P; Li G
    Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
    Ory B; Blanchard F; Battaglia S; Gouin F; Rédini F; Heymann D
    Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
    Bai J; Cederbaum AI
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1435-43. PubMed ID: 16971506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.